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ABSTRACT 
 Obesity during pregnancy is associated with a high risk of adverse maternal 
outcomes. Little is known about how weight change between consecutive pregnancies 
impacts subsequent pregnancy complications and newborn outcomes. This study aimed 
to explore the association between interpregnancy BMI change and adverse maternal 
outcomes, specifically, gestational diabetes mellitus (GDM), gestational hypertension, 
pre-eclampsia, non-repeat cesarean delivery (C-section), and vaginal birth after cesarean 
delivery (VBAC). The study sample was derived from the Eunice Kennedy Shriver 
National Institute of Child Health and Human Development Consecutive Pregnancy 
Study, which collected data from 20 hospitals in Utah utilizing electronic medical records 
and International Classification of Diseases ninth revision codes. The study collected 
extensive information on maternal demographic, reproductive and medical history, 
pregnancy complications, and labor and delivery information. Women with at least two 
pregnancies during the study period who delivered between 2002-2010 were included 
(n=51,086 women yielding 114,679 pregnancies). After data exclusions, the study sample 
included 46,521 women and the outcomes of their first two pregnancies. Between their 
first two consecutive pregnancies, these women gained an average of 0.81 BMI units 
(interquartile range (IQR) -0.34 to 1.77) over an average interpregnancy interval of 634 
days (IQR 373 to 814). Poisson regression with robust variance estimators was utilized to 
estimate the relative risks of the outcomes. After adjusting for potential confounders, 
every one unit increase in BMI between consecutive pregnancies increased the risk of 
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GDM (relative risk (RR): 1.09 (95% confidence interval (CI): 1.07 – 1.11)), pre-
eclampsia (RR: 1.06 (95% CI: 1.04 – 1.09)), and gestational hypertension in the second 
pregnancy increased (RR: 1.08 (95% CI: 1.06 – 1.10).  For every one unit increase in 
BMI, the risk of having a successful VBAC decreased (RR: 0.95 (95% CI: 0.93 – 0.98)). 
There was no significant association seen between interpregnancy BMI change and a 
non-repeat C-section.  Women with a BMI ≥ 3 units increase were also at a significantly 
increased risk of GDM (RR: 1.72 (95% CI: 1.52 – 1.93)), pre-eclampsia (RR: 1.61 (95% 
CI: 1.33 – 1.94)), and gestational hypertension (RR: 1.66 (95% CI: 1.42 – 1.93)) in the 
second pregnancy when compared to women who maintained their BMI between 
pregnancies (- 1 unit ≤ BMI change < 1 unit). The risk of having a successful VBAC 
decreased (RR: 0.72 (95% CI: 0.58 – 0.88) for women who gained ≥ 3 units, compared to 
women who maintained their BMI (- 1 unit ≤ BMI change < 1 unit). GDM was also 
increased among those who increased their BMI by at least 2 units but not more than 3 
units (RR: 1.40 (95% CI: 1.22 – 1.61)) and among those who gained at least 1 unit but no 
more than 2 BMI units (RR: 1.23 (95% CI: 1.08 – 1.40)). These findings have public 
health implications for the importance of weight management between pregnancies. 
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CHAPTER 1 
INTRODUCTION 
 
Nearly 56% of reproductive aged women (20-39 years of age) are overweight or obese1. 
Obesity during pregnancy is associated with a high risk of maternal and newborn adverse 
outcomes. Less is known about how weight change between two consecutive 
pregnancies, hereafter known as interpregnancy BMI or weight change, impacts 
subsequent pregnancy complications and newborn outcomes. In 2012, 41.6% of 15-50 
year old women in the US reported having two or more children2; thus, investigating the 
association between interpregnancy weight change and pregnancy complications is 
important. The best evidence for the impact of interpregnancy weight change on maternal 
health (pre-eclampsia, gestational hypertension, gestational diabetes mellitus (GDM), and 
cesarean delivery) comes from a study by Villamor and Cnattingius (2006)3. 
Using data from the Swedish Birth Register (n=151025 women), Villamor et al 
defined outcomes using the International Classifications of Diseases (ICD) ninth and 
tenth revisions3. They categorized the exposure into groups based on the participant’s 
change in BMI units from the first to the second pregnancy (range: >1 BMI unit decrease 
to ≥ 3 unit increase)3. Using logistic regression models, they found significant 
associations in the odds of pre-eclampsia [odds ratio (OR): 1.78; 95% confidence interval 
(CI): 1.52 – 2.08)]; gestational hypertension [OR: 1.76; 95% CI: 1.39 – 2.23]; GDM [OR: 
2.09; 95% CI: 1.68 – 2.61]; and cesarean section [OR: 1.32; 95% CI: 1.22 – 1.44] when
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comparing women with an interpregnancy BMI gain of 3 or more units to women with a 
change of -1 to 0.9 units3. These main findings are in line with the overall findings of 
subsequent studies4-12, 14, 15, which show that there is a positive association between an 
increase in intrepregnancy BMI and the risk of maternal adverse health outcomes. 
Studies similar to the Villamor and Cnattingius3 study have been conducted in the 
US. These studies utilized vital records data from Missouri4-9 or Washington10, 11 or had 
hospital-based cohort data12. Studies that used the vital statistics data examined the 
change in pre-pregnancy BMI between the first and second pregnancies as the exposure, 
which was categorized in different ways. One Missouri study, Mostello et al (2010)7, 
used the following categories: those who decreased their BMI ≥ 2 units; those who 
increased their BMI ≥ 2 units; and those who maintained their BMI within ± 2 units. The 
other Missouri studies4-6, 8, 9 utilized World Health Organization BMI categories13 
[underweight (BMI <18.5 kg/m2); normal (BMI: 18.50 – 24.99); overweight (BMI: 25.00 
– 29.99); obese (BMI ≥ 30.00)] classifying women based on their first and second pre-
pregnancy BMI. For example, a woman who has a normal BMI at the start of her first 
pregnancy and was overweight at the start of her second pregnancy would be classified as 
“normal-overweight”4-6, 8, 9. All of the studies adjusted for the first prepregnancy BMI 
group in their models along with other potential confounders4-5, 7-9. One study6 restricted 
their analysis to only include women whose first prepregnancy BMI was classified as 
overweight. The overall findings of the Missouri4-9 cohort studies illustrate that there is a 
positive association with interpregnancy BMI increase and the risk of adverse maternal 
outcomes in the second pregnancy/delivery; the exclusion criteria and findings of these 
studies are reported in Tables 1.1 and 1.2. 
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Vital records data from Washington State10, 11 have also been used to investigate 
the association between interpregnancy BMI change and adverse maternal outcomes. 
Paramsothy et al (2009)10 investigated the association between interpregnancy weight 
change and cesarean section in the second pregnancy among women with GDM using 
data collected from 1992-2005 (n=2753). Unlike the previously described studies, they 
categorized their exposure as weight change in pounds: weight loss greater than 10 
pounds (lbs); weight maintained (±10 lbs); weight gain of greater than 10 lbs and 
reported a significant association in the odds of having a cesarean delivery in the second 
pregnancy (OR: 1.70, 95% CI: 1.16 – 2.49) between women who gained more than 10 lbs 
and women with weight gain <10 lbs10. Another study utilizing data from Washington’s 
vital records was done by Callegari et al (2014)11.  They investigated the association 
between interpregnancy BMI change and vaginal birth after cesarean section (VBAC) 
utilizing data from 1992-2009 (n=8302)11. They categorized the exposure as follows: <1 
BMI unit decrease or increase; ≥ 1 BMI unit decrease; ≥ 1 and < 2 units increase; ≥ 2 
BMI units increase11. This study found that those with normal BMI before their first 
pregnancy had an 8% decrease in VBAC success with ≥ 1 and <2 BMI unit increase and 
a 12% decrease in success with ≥ 2 BMI unit increase compared with normal BMI 
women who maintained their weight11.  The results of these studies10, 11 further support 
the overall finding that an increase in interpregnancy weight is associated with an 
increased risk of adverse maternal outcomes in the second delivery, specifically GDM 
and VBAC. 
All of the studies enumerated above3-11 list the source of their data as a limitation. 
Vital records underreport the incidence of maternal complications compared to medical 
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records27-30.  DiGiuseppe et al (2002)27 utilized kappa statistics to investigate the 
agreement between vital records and medical records. For maternal risk factors and 
comorbidities, they report kappa statistics ranging from 0.085 – 0.54527. Additionally, for 
several complications of pregnancy and/or labor and delivery, they report kappa statistics 
ranging from 0.285 – 0.73427. Further, DiGiuseppe et al found high specificity (sp) for 
maternal risk factors, comorbidities, and pregnancy and/or labor and delivery 
complications (sp: 96.5 – 99.9%)27. In this instance, specificity is the probability that an 
individual did not report the outcome given that he or she did not have it. However, the 
same maternal risk factors, comorbidities, and complications resulted in lower 
sensitivities, which ranged from 8.6 – 65.4%27. Here, sensitivity is the probability that an 
individual reported the outcome given that he or she had it. Whether it is better to have a 
high sensitivity or specificity depends on the outcome, risk factor, or comorbidity of 
interest. DiGiuseppe et al conclude that utilizing vital records as opposed to medical 
records as a source for this type of data is ‘suspect’ at best27. 
To our knowledge, only one study in the US utilized a hospital-based cohort 
investigating the association between interpregnancy BMI change and GDM. Ehrlich et 
al (2011)12 used data from Kaiser Permanente Hospital System in Northern California 
(n=22351) to examine this association. They found that, compared to women who were 
weight stable (± <1 BMI unit change), interpregnancy weight gain was significantly 
associated with a higher risk of GDM in the second pregnancy. A gain of 1.0 – 1.9 BMI 
units had odds of subsequent GDM 1.71 times (95% CI: 1.42 – 2.07); a gain of 2.0 – 2.9 
BMI units had odds of subsequent GDM 2.46 times (95% CI: 2.00 – 3.02); a gain of 3.0 
or more BMI units had the odds of subsequent GDM 3.40 times (95% CI: 2.81 – 4.12)12. 
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Hospital-based cohort studies with larger sample sizes have been done in other countries, 
specifically Belgium14 and Scotland15.  The Belgian study investigated the association 
between interpregnancy BMI change and the risk of GDM, gestational hypertension, and 
caesarean section14. The Scottish study looked at the association between interpregnancy 
BMI change and the following maternal outcomes: pre-eclampsia, gestational 
hypertension, induced labor, elective caesarean, and emergency caesarean15. These 
studies, similar to Villamor and Cnattingius3, categorized the exposure into groups based 
on the unit change in their BMI from the first to second pregnancy, which ranged from 
>1 BMI unit decrease to ≥ 3 units increase. The overall findings of these international 
studies14,15 are in line with those seen with the Missouri 4-9 and Washington 10, 11 studies. 
The majority of previous studies that investigated the association between 
interpregnancy weight change and adverse maternal outcomes in the US utilized vital 
records4-11, which underreport maternal complications compared to medical records 
data27-30. In the US, hospital-based cohorts12 that investigate this association are rare; 
thus, there is a gap in the literature that calls for a US hospital-based cohort with a large 
sample size. Analysis of the longitudinal, retrospective Consecutive Pregnancy Study 
dataset from the Eunice Kennedy Shriver National Institute of Child Health and Human 
Development (NICHD) addresses this gap. The NICHD Consecutive Pregnancy study 
collected data from 20 hospitals in Utah from 2002 – 2010. We examined the association 
between interpregnancy BMI change and the following adverse maternal outcomes in the 
second delivery: gestational hypertension; GDM; pre-eclampsia; non-repeat cesarean 
section; and VBAC. In line with the findings of previous literature, we hypothesized that 
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there is a positive association between interpregnancy BMI increase and the risk of 
adverse maternal outcomes. 
 
Table 1.1: Details of Missouri vital records-based cohorts: cohort years, sample size, and 
exclusions4-9 
 
Author 
(year) 
Cohort 
years 
(sample 
size) 
Study sample exclusion criteria 
Getahun 
(2007)4 
1989-1997 
(n=113,789) 
Those with only 1 pregnancy during study period; those 
that were not nulliparous at baseline; multiple births; 
stillbirths; missing data: maternal weight and height, births 
at <20 weeks gestation, cesarean; vaginal birth after 
cesarean (VBAC); repeated cesarean  
Getahun 
(2007)5 
1989-1997 
(n=136,884) 
Those with only 1 pregnancy during study period; those 
that were not nulliparous at baseline; multiple births; 
missing data: maternal height and weight; those with: 
chronic hypertension, chronic/gestational diabetes, pre-
eclampsia in first pregnancy, pregnancies <20 weeks 
gestation 
Hoff 
(2009)6 
1995-2004 
(n=1,035) 
If their prepregnancy BMI was not classified overweight 
(BMI 25.0 – 29.9 kg/m2) for the first pregnancy; those with 
only 1 pregnancy during study period; those that were not 
nulliparous at baseline; multiple births 
Mostello 
(2010)7 
1989-2005 
(n=17,773) 
Those with only 1 pregnancy during study period; those 
that were not nulliparous at baseline; multiple births; those 
whose first pregnancy was not complicated by pre-
eclampsia 
Whiteman 
(2011)8 
1989-2005 
(n=232,272) 
Those with only 1 pregnancy during study period; those 
that were not nulliparous at baseline; births at <20 weeks 
gestation 
Whiteman 
(2011)9 
1989-2005 
(n=100,828) 
Those with only 1 pregnancy during study period; those 
that were not nulliparous at baseline; those that were 
classified as overweight for either pregnancy; births at <20 
weeks gestation; those without vaginal birth for first 
pregnancy 
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Table 1.2: Details of Missouri vital records-based cohorts: outcomes and main findings4-9  
 
Author 
(year) 
Outcome(s) 
in second 
pregnancy 
Main findings 
Getahun 
(2007)4 
Primary 
cesarean 
Increase in BMI from underweight to overweight or obese 
within the first two pregnancies associated with increased 
risk of primary cesarean (odds ratio (OR) 1.20 to 3.04)) in 
second delivery 
Getahun 
(2007)5 
Pre-eclampsia 
incidence 
Risk for pre-eclampsia increased when BMI category in 
first pregnancy was underweight and change to obese in 
second pregnancy (OR: 5.6 (95% CI: 1.7 18.2); normal to 
overweight (2.0 (1.7, 2.3); normal to obese (3.2 (2.5, 4.2); 
overweight to obese (3.7 (3.1, 4.3) 
Hoff 
(2009)6 
Pregnancy 
hypertension; 
emergency 
cesarean 
section 
Upward BMI shift significantly associated with 
emergency cesarean section (p-value <0.02) 
Mostello 
(2010)7 
Recurrent 
pre-eclampsia 
Increase in BMI significantly associated with higher risk 
of recurrent pre-eclampsia (risk ratio (RR): 1.29 (95% CI: 
1.20, 1.38); decrease in BMI significantly associated with 
lower risk of recurrent pre-eclampsia (RR: 0.70 (0.60, 
0.81)) 
Whiteman 
(2011)8 
Development 
of diabetes 
(gestational 
or type II 
diabetes 
mellitus) 
Mothers who moved from normal to obese BMI 
categories between pregnancies had increased risk (OR: 
3.21 (2.76, 3.73)) of developing diabetes in the second 
pregnancy 
Whiteman 
(2011)9 
Primary 
cesarean 
(emergency 
and non-
emergency) 
Mothers who moved from normal to obese BMI 
categories between pregnancies had increased risk (OR: 
1.41 (1.26, 1.57)) of cesarean delivery in the second 
pregnancy; mothers who maintained obese status between 
pregnancies also at increased risk (OR: 1.75 (1.65, 1.87) 
of cesarean delivery in the second pregnancy 
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CHAPTER 2 
METHODS 
2.1 STUDY POPULATION 
The NICHD Consecutive Pregnancy Study enrolled a total of 51,086 women, 
regardless of their parity, with at least two pregnancies (range 2-6 pregnancies) who 
delivered between the years 2002 to 2010, which resulted in 114,679 pregnancies (live 
births or stillbirths ≥ 20 weeks’ gestation). Data sources included electronic medical 
records (EMR) and ICD-9 codes collected from maternal and newborn discharge 
summaries and linked to each delivery. Extensive information on maternal demographic, 
reproductive and medical history, pregnancy complications, labor and delivery 
information, and neonatal outcomes were available. All study sites had approval for the 
study and waiver of informed consent from their individual institutional review boards.  
2.2 DATA EXCLUSIONS 
For the current study, the sample was restricted to each woman’s first two 
singleton births (n=49,868) regardless of her parity upon enrollment in the study. Women 
with inconsistencies in their hypertensive status, such as being prescribed hypertensive 
medication or having hypertension as a labor indication without having hypertension 
(n=202); inconsistencies in their diabetes status, such as having an ICD-9 code for ‘infant 
of a diabetic mother’ with no diabetes recorded for the mother (n=23); with chronic 
diseases in their first pregnancy including diabetes mellitus, chronic hypertension, or 
superimposed pre-eclampsia (n = 920); with missing height or weight data in either 
pregnancy (n = 1546); with implausible BMI values, which was defined as 
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11 kg/m2 > BMI > 70 kg/m2 (n=1); and those with chronic hypertension, diabetes 
mellitus, or superimposed pre-eclampsia in their second pregnancy (n=655) were 
excluded resulting in 46,521 women for the current study (see figure 1). The 
demographics of those missing height or weight data differed slightly from those with 
data (supplementary table A.1). At the time of the second pregnancy, more of those 
missing data identified as Hispanic (27.72%); characterized themselves as single 
(13.91%); and smoked (4.22%), compared to those who were not missing data, who had 
rates of 10.09%, 7.93%, and 3.07%, respectively. Of those missing data, fewer had 
private insurance (61.06%) than those who were not missing data (74.16%). Those 
missing data had a higher incidence of gestational diabetes mellitus in the second 
pregnancy (5.89%) than those who were not missing data (3.54%). The incident rates of 
the other maternal second pregnancy outcomes did not differ substantially between the 
two groups (supplementary table A.1). 
2.3 INTERPREGNANCY BMI CHANGE 
The exposure, interpregnancy weight change, was calculated as the difference 
between the prepregnancy BMI of the first pregnancy and the prepregnancy BMI of the 
second pregnancy and was examined as both a continuous and a categorical variable as: 
difference in BMI <-1 units (i.e. loss of more than 1 BMI unit (kg/m2)), -1 to less than 1 
(reference group), 1 to less than 2, 2 to less than 3, and ≥ 3 BMI units (i.e. gain of 3 or 
more BMI units).  
2.4 MATERNAL OUTCOMES 
Maternal outcomes in the second pregnancy were ascertained from electronic 
medical records supplemented with ICD-9 codes and included: pre-eclampsia, gestational 
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hypertension, gestational diabetes, vaginal birth after cesarean delivery (VBAC), and 
non-repeat cesarean delivery. If the condition was coded in either source, then the woman 
was coded as having the diagnosis. During the study period, the definitions that were 
widely adopted in US clinical practice were utilized to identify the outcomes of interest. 
These definitions were as follows: pre-eclampsia and gestational hypertension defined as 
systolic blood pressure ≥ 140 mmHg, a diastolic blood pressure ≥ 90 mmHg occurring 
after 20 weeks’ gestation among previously normotensive women with and without 
proteinuria and urinary excretion ≥ 0.3 grams of protein in 24-hour urine specimen, 
respectively17, 18. Mode of delivery (VBAC or non-repeat cesarean delivery (C-section)) 
was determined via the EMR. The denominator for the VBAC outcome was restricted to 
only include those who had a C-section in their first delivery (n=5132). Those with a C-
section in the first delivery were excluded from the non-repeat cesarean delivery 
denominator (n=41389). Gestational diabetes was determined via diagnosis in the EMR 
and was supplemented with ICD-9 codes. ICD-9 codes for the examined maternal 
outcomes are listed in the supplementary table A.2. 
2.5 STATISTICAL ANALYSIS 
Potential confounders of the association between interpregnancy BMI change and the 
maternal outcomes are as follows: maternal race (categorized as: White; Hispanic; or 
Black/Asian/Pacific Islander/other); maternal age (measured at pregnancy 2); 
interpregnancy interval (measured as days between first delivery date and last menstrual 
period for second pregnancy); smoking and alcohol use during the second pregnancy 
(yes/no); pre-eclampsia, gestational hypertension, or gestational diabetes mellitus in the 
first pregnancy (yes/no); and first prepregnancy BMI. Because there is potentially more 
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variability in diagnosis between hospitals, the association was also adjusted for hospital 
site. 
Poisson regression models with robust variance estimators were used to estimate 
the relative risk of the outcome while adjusting for these potential confounders19. 
Unadjusted and adjusted analyses were performed for each outcome, for which two 
Poisson regression models were built, treating interpregnancy BMI change as either 
categorical or continuous. Significance was evaluated at α = 0.05. 
Two sensitivity analyses were performed utilizing the same approach described 
above. The first sensitivity analysis restricted the sample to women who were nulliparous 
upon entry in the study (n=25429). Next, a sensitivity analysis was performed in which 
women who had any of the examined outcomes in their first pregnancy were excluded 
(gestational hypertension: n=1784; pre-eclampsia: n=1516; GDM: n=914). Of the women 
in this sample, 50 had both GDM and pre-eclampsia in their first pregnancy; 42 had both 
gestational hypertension and GDM in their first pregnancy. The final sample size was 
n=42399. Statistical analyses were conducted using software (SAS, version 9.4; SAS 
institute, Cary, NC).
 12 
 
 
 
          
           Figure 2.1: Study Sample Exclusions
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CHAPTER 3 
RESULTS 
Study participants gained an average of 0.81 BMI units (median 0.46, interquartile range 
(IQR) -0.34 to 1.77) over an average interpregnancy interval of 634 days (median 561, 
IQR 373 to 814).  At the first prepregnancy measurement, 20.69% of women were 
overweight (25 ≤ BMI < 30) and 11.97% of women were obese (BMI ≥ 30). While, at the 
second prepregnancy measurement 23.16% of women were overweight and 15.92% of 
women were obese. At the time of the second pregnancy, most study participants were 
married (90.42%); had private insurance (74.16%); identified as White (87.05%); had a 
vaginal birth in their second delivery (78.54%); and were nulliparous upon entry into the 
study (54.66%). The average age of the women at the second delivery was 28 years old 
(median 28, IQR 25 to 31). Women who identified as single had the highest mean change 
in BMI (1.50 BMI units (standard deviation (SD) = 3.02)), compared to women who 
identified as married or divorced/widowed. Hispanic women had the highest mean 
change in BMI (1.32 (SD: 2.73)), compared to women who identified as White, Black, 
Asian, Pacific Islander, or other. Women who had pregnancy complications in the second 
pregnancy including GDM, gestational hypertension, or preeclampsia gained on average 
around 1.4 to 1.5 (SD: 2.9) BMI units. The sample characteristics of the study 
participants are described in table 3.1.  
Within the study population, the incidence rates of maternal outcomes in the 
second pregnancy were as follows: gestational hypertension: 2.31%; GDM: 3.54%; pre-
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eclampsia: 1.70%; non-repeat C-section: 2.09%; VBAC: 16.02% (table 3.2). The greatest 
frequency of most of the outcomes was seen among those with the largest increase in 
interpregnancy BMI (≥ +3 units, n=6376). Within this group at the second delivery, 
5.87% had GDM; 4.39% had gestational hypertension; 3.12% had pre-eclampsia; 1.87% 
had a non-repeat C-section; and 10.51% had a VBAC (table 3.2).  
After adjusting for potential confounders, for every one unit increase in BMI 
between consecutive pregnancies, the risk of having GDM (relative risk (RR): 1.09 (95% 
CI: 1.07 – 1.11)), pre-eclampsia (RR: 1.06 (95% CI: 1.04 – 1.09)), and gestational 
hypertension in the second pregnancy increased (RR: 1.08 (95% CI: 1.06 – 1.10); while, 
the risk of having a successful VBAC decreased (RR: 0.95 (95% CI: 0.93 – 0.98)) (table 
3.3). There was no significant association seen between interpregnancy BMI change and 
a non-repeat C-section. When interpregnancy BMI change was treated categorically, a 
similar trend was seen (table 3.4). A woman with an interpregnancy BMI gain of 3 or 
more units was at a higher risk of developing GDM (relative risk (RR): 1.72, 95% CI: 
1.52 – 1.93), pre-eclampsia (RR: 1.61, 95% CI: 1.33 – 1.94), gestational hypertension 
(RR: 1.66, 95% CI:1.42 – 1.93), than those who maintained their interpregnancy BMI, 
after adjusting for potential confounders (table 3.4). A woman with an interpregnancy 
BMI gain of 3 or more units was less likely to have a successful VBAC (RR: 0.72 (95% 
CI: 0.58 – 0.88), than those who maintained their interpregnancy BMI, after adjusting for 
potential confounders (table 3.4). This group’s risk of a non-repeat C-section did not 
differ from those who maintained their BMI between consecutive pregnancies after 
potential confounders were considered (table 3.4). 
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Compared to those who maintained their BMI between pregnancies (-1 ≤ BMI 
unit change < +1), those who increased their BMI by at least 2 units but not more than 3 
units showed an increased risk of having GDM in the second pregnancy (RR: 1.40 (95% 
CI: 1.22 – 1.61)), after adjusting for potential confounders (table 3.4). This group did not 
differ in their risk of pre-eclampsia, gestational hypertension, non-repeat C-section, or 
VBAC, in comparison to those who maintained their BMI between pregnancies, after 
potential confounders were considered (table 3.4).   
Compared to those who maintained their BMI between pregnancies, those who 
gained +1 ≤ BMI unit < 2 were at a higher risk of having GDM in the second pregnancy 
(RR: 1.23 (95% CI: 1.08 – 1.40)) and at a higher risk of having an unsuccessful VBAC 
(RR: 0.77 (95% CI: 0.64 – 0.94), after adjusting for potential confounders (table 3.4).  
This group’s risk of pre-eclampsia, gestational hypertension, and non-repeat C-section 
did not differ from those who maintained their BMI between consecutive pregnancies, 
after potential confounders were considered (table 3.4). 
Weight loss of more than one BMI unit between consecutive pregnancies was not 
significantly associated with an increased risk of GDM, pre-eclampsia, gestational 
hypertension, non-repeat cesarean section, or VBAC, after adjusting for potential 
confounders (table 3.4). 
The results of the two sensitivity analyses did not differ from the findings of the 
full data. The findings for the nulliparous sensitivity analyses are reported for BMI 
change as continuous (table 3.5) and as categorical (table 3.6). Of the nulliparous sample, 
739 (2.91%) had GDM; 599 (2.36%) had gestational hypertension; 2 (<0.01%) had a 
non-repeat C-section; 619 (14.01%) had a VBAC; and 465 (1.83%) had pre-eclampsia. 
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Similarly, the findings for excluding women who had any outcome in the first pregnancy 
(GDM, gestational hypertension, pre-eclampsia) are reported for BMI change as 
continuous (table 3.7) and as categorical (table 3.8). In this second sensitivity analysis, 
812 (1.92%) had GDM; 587 (1.38%) had gestational hypertension; 828 (2.17%) had a 
non-repeat C-section; 741 (17.35%) had a VBAC; and 464 (1.09%) had pre-eclampsia.
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Table 3.1: Sample Characteristics of NICHD Consecutive Pregnancy Study from 20 hospitals in Utah 
(n=46521) 
 
Characteristic Second Pregnancy p-value* Mean change in BMI (SD) 
First pregnancy BMI category, n (%)  <0.0001  
  Underweight (BMI < 18.5) 2738 (5.89)  0.95 (1.64) 
  Normal (18.5 ≤ BMI < 25) 28591 (61.46)  0.77 (1.94) 
  Overweight (25 ≤ BMI < 30) 9623 (20.69)  0.97 (2.73) 
  Obese (BMI ≥ 30) 5569 (11.97)  0.74 (3.56) 
Marital status, n (%)  <0.0001  
  Married 42063 (90.42)  0.75 (2.26) 
  Divorced/Widowed 767 (1.65)  0.98 (3.06) 
  Single 3742 (7.93)  1.50 (3.02) 
Private insurance, n (%) 34498 (74.16) <0.0001 0.69 (2.18) 
Maternal race, n (%)  <0.0001  
  White 40457 (87.05)  0.74 (2.29) 
  Hispanic 4691 (10.09)  1.32 (2.73) 
  Black/Asian/Pacific Islander/Other 1328 (2.86)  1.28 (2.72) 
Lifestyle behaviors    
  Smoking during pregnancy 2, n (%) 1427 (3.07) <0.0001 1.07 (3.12) 
  Alcohol use during pregnancy 2, n (%) 696 (1.50) <0.0001 1.03 (2.86) 
Gestational diabetes mellitus, n (%) 1646 (3.54) <0.0001 1.39 (2.85) 
Gestational hypertension, n (%) 1073 (2.31) <0.0001 1.54 (2.88) 
Pre-eclampsia, n (%) 791 (1.70) <0.0001 1.42 (2.92) 
Delivery mode, n (%)  <0.0001  
  Vaginal birth 36539 (78.54)  0.77 (2.26) 
  Vaginal birth after cesarean in first delivery 1685 (3.62)  0.69 (2.22) 
  Non-repeat cesarean in second delivery 1603 (3.45)  0.94 (2.64) 
  Repeat cesarean in second delivery 6693 (14.39)  1.07 (2.77) 
*Chi-square test 
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Table 3.1 continued: Sample characteristics of NICHD Consecutive Pregnancy Study from 20 
hospitals in Utah (n=46521) 
 
Characteristic Second Pregnancy p-value* Mean change in BMI (SD) 
Maternal age, years, n (%)  <0.0001  
  < 35 42268 (90.86)  0.83 (2.37) 
  ≥ 35 4253 (9.14)  0.68 (2.23) 
Maternal age, years, mean (SD) 27.97 (4.63)   
Parity  <0.0001  
  1 25429 (54.66)  0.90 (2.43) 
  2 10624 (22.84)  0.75 (2.26) 
  3 6461 (13.89)  0.68 (2.26) 
  4 2507 (5.39)  0.71 (2.24) 
  5 925 (1.99)  0.67 (2.27) 
  6+ 575 (1.24)  1.18 (1.89) 
Interpregnancy interval  <0.0001  
  0 – 5 months 2402 (5.16)  1.03 (2.37) 
  6 – 11 months 7536 (16.20)  0.73 (2.24) 
  12 – 17 months 11065 (23.78)  0.57 (2.14) 
  18 – 23 months 9630 (20.70)  0.64 (2.23) 
  24 – 59 months 15332 (32.96)  1.07 (2.54) 
  ≥ 60 months 556 (1.20)  1.88 (3.36) 
Interpregnancy interval, months, mean (SD) 21.15 (12.31)   
*Chi-square test     
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Table 3.2:  Outcomes in second pregnancy by BMI change regardless of parity at baseline (N=46521), n (%) 
 
BMI unit change GDM 
n = 1646 
Gestational 
hypertension 
n = 1073 
Pre-eclampsiac 
n = 791 
Non-repeat 
C-sectiona 
n = 863 
VBACb 
n = 822 
 
BMI unit change < -1 
(n=6560) 
228 (3.48) 134 (2.04) 114 (1.74) 120 (2.07) 121 (16.09) 
-1 ≤ BMI unit change < + 1 
(n=22838) 
609 (2.67) 408 (1.79) 304 (1.33) 437 (2.12) 426 (19.15) 
+ 1 ≤ BMI unit change < + 2 
(n=6737) 
239 (3.55) 151 (2.24) 108 (1.60) 119 (1.99) 103 (13.79) 
+2  ≤ BMI unit change < + 3 
(n=4010) 
196 (4.89) 100 (2.49) 66 (1.65) 86 (2.41) 71 (15.85) 
BMI unit change ≥ + 3 
(n=6376) 
374 (5.87) 280 (4.39) 199 (3.12) 101 (1.87) 101 (10.51) 
p-valuec <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 
aDenominator excludes anyone with a c-section in the first pregnancy (n = 41389); bDenominator only includes 
those with c-section in first pregnancy (n=5132); cChi-square test 
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Table 3.3: Relative risks (95% confidence intervals) of maternal outcomes by 
BMI difference (continuous) between consecutive pregnancies (n=46521) 
 
Maternal Outcome in Second Pregnancy BMI difference (continuous) 
GDM  
  Unadjusted 1.10 (1.08 – 1.12)** 
  Adjusteda 1.09 (1.07 – 1.11)** 
Pre-eclampsia  
  Unadjusted 1.10 (1.07 – 1.13)** 
  Adjusteda 1.06 (1.04 – 1.09)** 
Gestational hypertension  
  Unadjusted 1.12 (1.09 – 1.14)** 
  Adjusteda 1.08 (1.06 – 1.10)** 
Non-repeat C-section  
  Unadjusted 0.98 (0.95 – 1.00)* 
  Adjusteda 0.99 (0.96 – 1.02) 
VBAC  
  Unadjusted 0.95 (0.93 – 0.97)** 
  Adjusteda 0.95 (0.93 – 0.98)** 
aAdjusted for: maternal race (referent level: white); maternal age; 
interpregnancy interval; smoking during 2nd pregnancy (referent level: yes); 
alcohol use during 2nd pregnancy (referent level: yes); Pre-eclampsia in 1st 
pregnancy (referent level: yes); gestational hypertension in 1st pregnancy 
(referent level: yes); GDM in 1st pregnancy (referent level: yes); pre-
pregnancy 1 BMI; hospital site. *Marginally significant at α = 0.05 level 
**Significant at α = 0.05 level 
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Table 3.4: Relative risks (95% confidence intervals) of maternal outcomes by BMI change (categorical) between consecutive 
pregnancies (n=46521) – Referent level: - 1 unit ≤ BMI change < 1 unit 
 
Maternal Outcome in 
Second Pregnancy 
BMI change < -1 unit BMI change 1 to less 
than 2 units 
BMI change 2 to less 
than 3 
BMI change ≥ 3 units 
GDM     
  Unadjusted 1.30 (1.12 – 1.51)** 1.33 (1.15 – 1.54)** 1.83 (1.57 – 2.15)** 2.20 (1.94 – 2.49)** 
  Adjusteda 0.90 (0.79 – 1.02) 1.23 (1.08 – 1.40)** 1.40 (1.22 – 1.61)** 1.72 (1.52 – 1.93)** 
Pre-eclampsia     
  Unadjusted 1.31 (1.05 – 1.62)** 1.20 (0.97 – 1.50) 1.24 (0.95 – 1.50) 2.34 (1.97 – 2.80)** 
  Adjusteda 0.97 (0.78 – 1.20) 1.03 (0.83 – 1.28) 1.00 (0.77 – 1.30) 1.61 (1.33 – 1.94)** 
Gestational hypertension     
  Unadjusted 1.14 (0.94 – 1.39) 1.25 (1.04 – 1.51)** 1.40 (1.12 – 1.73)** 2.46 (2.12 – 2.85)** 
  Adjusteda 0.83 (0.69 – 1.01) 1.10 (0.91 – 1.31) 1.10 (0.89 – 1.36) 1.66 (1.42 – 1.93)** 
Non-repeat C-section     
  Unadjusted 0.97 (0.80 – 1.19) 0.94 (0.77 – 1.15) 1.14 (0.91 – 1.43) 0.88 (0.71 – 1.09) 
  Adjusteda 0.99 (0.81 – 1.22) 0.92 (0.75 – 1.13) 1.15 (0.92 – 1.45) 1.01 (0.81 – 1.25) 
VBAC     
  Unadjusted 0.84 (0.70 – 1.01) 0.72 (0.59 – 0.88)** 0.83 (0.66 – 1.04) 0.55 (0.45 – 0.67)** 
  Adjusteda 1.06 (0.88 – 1.27) 0.77 (0.64 – 0.94)** 0.98 (0.78 – 1.23) 0.72 (0.58 – 0.88)** 
aAdjusted for: maternal race (referent level: white); maternal age; interpregnancy interval; smoking during 2nd pregnancy 
(referent level: yes); alcohol use during 2nd pregnancy (referent level: yes); Pre-eclampsia in 1st pregnancy (referent level: 
yes); gestational hypertension in 1st pregnancy (referent level: yes); GDM in 1st pregnancy (referent level: yes); pre-
pregnancy 1 BMI; hospital site. *Marginally significant at α = 0.05 level **Significant at α = 0.05 level 
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Table 3.5: Relative risks (95% confidence intervals) of maternal outcomes by 
BMI difference (continuous) between consecutive pregnancies among 
nulliparous women at baseline (n=25429) 
 
Maternal Outcome in Second Pregnancy BMI difference (continuous) 
GDM  
  Unadjusted 1.12 (1.09 – 1.14)** 
  Adjusteda 1.11 (1.08 – 1.13)** 
Pre-eclampsia  
  Unadjusted 1.10 (1.06 – 1.13)** 
  Adjusteda 1.06 (1.03 – 1.09)** 
Gestational hypertension  
  Unadjusted 1.12 (1.09 – 1.15)** 
  Adjusteda 1.08 (1.05 – 1.10)** 
Non-repeat C-section  
  Unadjusted -b 
  Adjusteda -b 
VBAC  
  Unadjusted 0.95 (0.92 – 0.97)** 
  Adjusteda 0.95 (0.92 – 0.98)** 
aAdjusted for: maternal race (referent level: white); maternal age; 
interpregnancy interval; smoking during 2nd pregnancy (referent level: yes); 
alcohol use during 2nd pregnancy (referent level: yes); Pre-eclampsia in 1st 
pregnancy (referent level: yes); gestational hypertension in 1st pregnancy 
(referent level: yes); pre-pregnancy 1 BMI; GDM in 1st pregnancy (referent 
level: yes); hospital site; bModels did not converge; outcome not frequent 
enough (prevalence = 2/21010); **Significant at α = 0.05 level 
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Table 3.6: Relative risks (95% confidence intervals) of maternal outcomes by BMI change (categorical) between consecutive 
pregnancies of nulliparous women at baseline (n=25429) – Referent level: - 1 unit ≤ BMI change < 1 unit 
 
Maternal Outcome in 
Second Pregnancy 
BMI change < -1 unit BMI change 1 to less 
than 2 units 
BMI change 2 to less 
than 3 
BMI change ≥ 3 units 
GDM     
  Unadjusted 1.06 (0.83 – 1.35) 1.33 (1.06 – 1.66)** 1.84 (1.45 – 2.33)** 2.24 (1.87 – 2.69)** 
  Adjusteda 0.87 (0.71 – 1.07) 1.28 (1.05 – 1.56)** 1.58 (1.27 – 1.96)** 1.87 (1.58 – 2.23)** 
Pre-eclampsia     
  Unadjusted 1.19 (0.89 – 1.59) 1.43 (1.08 – 1.87)** 1.19 (0.84 – 1.69) 2.22 (1.78 – 2.80)** 
  Adjusteda 0.93 (0.70 – 1.24) 1.15 (0.88 – 1.51) 0.99 (0.70 – 1.41) 1.52 (1.19 – 1.94)** 
Gestational hypertension     
  Unadjusted 0.96 (0.73 – 1.26) 1.27 (0.99 – 1.62) 1.37 (1.03 – 1.83)** 2.30 (1.89 – 2.80)** 
  Adjusteda 0.75 (0.58 – 0.98) 1.03 (0.81 – 1.32) 1.10 (0.83 – 1.46) 1.52 (1.24 – 1.87)** 
Non-repeat C-section     
  Unadjusted -b -b -b -b 
  Adjusteda -b -b -b -b 
VBAC     
  Unadjusted 0.92 (0.75 – 1.14) 0.74 (0.59 – 0.93)** 0.84 (0.64 – 1.10) 0.57 (0.45 – 0.71)** 
  Adjusteda 1.17 (0.95 – 1.44) 0.78 (0.62 – 0.98)** 1.00 (0.76 – 1.32) 0.72 (0.57 – 0.92)** 
aAdjusted for: maternal race (referent level: white); maternal age; interpregnancy interval; smoking during 2nd pregnancy 
(referent level: yes); alcohol use during 2nd pregnancy (referent level: yes); Pre-eclampsia in 1st pregnancy (referent level: 
yes); gestational hypertension in 1st pregnancy (referent level: yes); GDM in 1st pregnancy (referent level: yes); pre-
pregnancy 1 BMI; hospital site; bModels did not converge; outcome not frequent enough (prevalence = 3/21208);  
*Marginally significant at α = 0.05 level **Significant at α = 0.05 level 
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Table 3.7: Relative risks (95% confidence intervals) of maternal outcomes by 
BMI difference (continuous) between consecutive pregnancies – excluding 
those who had any outcome in the first pregnancy (n=42399) 
 
Maternal Outcome in Second Pregnancy BMI difference (continuous) 
GDM  
  Unadjusted 1.16 (1.13 – 1.18)** 
  Adjusteda 1.13 (1.11 – 1.16)** 
Pre-eclampsia  
  Unadjusted 1.11 (1.07 – 1.15)** 
  Adjusteda 1.08 (1.05 – 1.12)** 
Gestational hypertension  
  Unadjusted 1.14 (1.11 – 1.18)** 
  Adjusteda 1.12 (1.09 – 1.15)** 
Non-repeat C-section  
  Unadjusted 0.98 (0.95 – 1.01) 
  Adjusteda 0.99 (0.96 – 1.02) 
VBAC  
  Unadjusted 0.94 (0.92 – 0.97)** 
  Adjusteda 0.94 (0.91 – 0.97)** 
aAdjusted for: maternal race (referent level: white); maternal age; 
interpregnancy interval; smoking during 2nd pregnancy (referent level: yes); 
alcohol use during 2nd pregnancy (referent level: yes); Pre-eclampsia in 1st 
pregnancy (referent level: yes); gestational hypertension in 1st pregnancy 
(referent level: yes); pre-pregnancy 1 BMI; GDM in 1st pregnancy (referent 
level: yes); hospital site. **Significant at α = 0.05 level 
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Table 3.8: Relative risks (95% confidence intervals) of maternal outcomes by BMI change (categorical) between consecutive 
pregnancies – excluding those who had any outcome in the first pregnancy (n=42399) – Referent level: - 1 unit ≤ BMI 
change < 1 unit 
 
Maternal Outcome in 
Second Pregnancy 
BMI change < -1 unit BMI change 1 to less 
than 2 units 
BMI change 2 to less 
than 3 
BMI change ≥ 3 units 
GDM     
  Unadjusted 1.09 (0.85 – 1.38) 1.62 (1.32 – 1.99)** 2.09 (1.66 – 2.62)** 2.94 (2.47 – 3.50)** 
  Adjusteda 0.83 (0.65 – 1.06) 1.43 (1.16 – 1.75)** 1.75 (1.39 – 2.19)** 2.27 (1.88 – 2.73)** 
Pre-eclampsia     
  Unadjusted 1.13 (0.85 – 1.50) 1.11 (0.84 – 1.48) 1.04 (0.72 – 1.49) 2.24 (1.78 – 2.82)** 
  Adjusteda 0.84 (0.63 – 1.13) 0.98 (0.74 – 1.31) 0.87 (0.60 – 1.26) 1.65 (1.28 – 2.13)** 
Gestational hypertension     
  Unadjusted 1.07 (0.81 – 1.40) 1.35 (1.05 – 1.72)** 1.20 (0.87 – 1.65) 2.90 (2.38 – 3.53)** 
  Adjusteda 0.78 (0.59 – 1.02) 1.24 (0.97 – 1.59) 1.03 (0.75 – 1.42) 2.23 (1.81 – 2.75)** 
Non-repeat C-section     
  Unadjusted 1.00 (0.82 – 1.23) 0.94 (0.76 – 1.15) 1.13 (0.89 – 1.43) 0.90 (0.72 – 1.12) 
  Adjusteda 1.01 (0.82 – 1.25) 0.91 (0.74 – 1.12) 1.12 (0.89 – 1.42) 1.00 (0.80 – 1.25) 
VBAC     
  Unadjusted 0.88 (0.73 – 1.06) 0.73 (0.59 – 0.90)** 0.85 (0.66 – 1.08) 0.53 (0.43 – 0.67)** 
  Adjusteda 1.10 (0.91 – 1.33) 0.79 (0.64 – 0.97)** 0.97 (0.76 – 1.23) 0.68 (0.54 – 0.85)** 
aAdjusted for: maternal race (referent level: white); maternal age; interpregnancy interval; smoking during 2nd pregnancy 
(referent level: yes); alcohol use during 2nd pregnancy (referent level: yes); Pre-eclampsia in 1st pregnancy (referent level: 
yes); gestational hypertension in 1st pregnancy (referent level: yes); GDM in 1st pregnancy (referent level: yes); pre-
pregnancy 1 BMI; hospital site. *Marginally significant at α = 0.05 level **Significant at α = 0.05 level 
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CHAPTER 4 
DISCUSSION 
We found that there was a significant association between a one unit increase in BMI 
between consecutive pregnancies and increased risk of GDM, gestational hypertension, 
pre-eclampsia, and an unsuccessful VBAC in the second pregnancy when potential 
confounders were taken into consideration. No association was found between 
interpregnancy BMI change and non-repeat C-section. The highest magnitude of risk of 
these adverse maternal outcomes was seen when comparing the group with the largest 
increase in interpregnancy BMI (≥ +3 units), which for this study was representative of 
13.79% of participants, with those who maintained their interpregnancy BMI (-1 unit ≤ 
BMI change < 1 unit), which was representative of 49.38% of participants. Overall, the 
results of the current study were in line with findings of previous studies3-12, 14, 15; 
however, it must be noted that all of the previous studies except for one12 utilized vital 
records data, which tend to underreport maternal complications27-30 compared to medical 
records. 
4.1 GESTATIONAL DIABETES MELLITUS (GDM) 
We found that any increase in BMI between consecutive pregnancies was significantly 
associated with an elevated risk of GDM, compared with those who maintained their 
BMI. We found that a BMI increase of ≥ 3 units had a risk 1.72 (95% CI: 1.52 – 1.93) 
times that of those who maintained their BMI. When comparing those same groups, 
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Villamor and Cnattingius found an odds ratio of GDM in the second pregnancy of 2.09 
(95% CI: 1.68 – 2.61)3. Although both Whiteman et al8 and Ehrlich et al12 categorized 
their exposures differently, they found significant associations between an increase in 
BMI and an increase of GDM risk in the second pregnancy. Bogaerts et al14 found that 
this association was only significant in those who had a BMI < 25 at the first 
prepregnancy measurement. Unlike the findings of the current study, both Whiteman et 
al8 and Ehrlich et al12 found that as BMI decreased between consecutive pregnancies, the 
odds of GDM in the second pregnancy decreased. However, Ehrlich et al12 only found 
this amongst women who were categorized as overweight or obese in their first 
pregnancy. Also, because Whiteman et al8 categorized their exposure differently, it may 
be difficult to compare their results to the current study. 
4.2 PRE-ECLAMPSIA 
We found that an increase in BMI between consecutive pregnancies was associated with 
an increased risk of pre-eclampsia in the second pregnancy. A BMI increase of ≥ 3 units 
(compared to interpregnancy BMI maintenance) was associated with a RR of 1.61 (95% 
CI: 1.33 – 1.94) of pre-eclampsia. Villamor and Cnattingius3 and Wallace et al15 
categorized the exposure the same way we did and found that if a woman increases her 
BMI ≥ 3 units between consecutive pregnancies, her odds of pre-eclampsia in the second 
pregnancy increases. Although Getahun et al5 categorized their exposure differently than 
our current study, they found a similar positive significant association. Mostello et al7 
only looked at recurrent pre-eclampsia in the second pregnancy. Similar to our results, 
they found that as BMI increases, the odds of pre-eclampsia in the second pregnancy 
increases. However, they also found that as BMI decreases, the odds of pre-eclampsia 
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decreases. As they only included those with pre-eclampsia in their first pregnancy, it may 
not be appropriate to compare the results of Mostello et al7 to our results. 
4.3 GESTATIONAL HYPERTENSION 
We found that a BMI increase of ≥ 3 units between consecutive pregnancies had an 
elevated risk of gestational hypertension in the second pregnancy 1.66 times that of 
women who maintained their weight (95% CI: 1.42 – 1.93). Both Villamor and 
Cnattingius3 and Wallace et al15 found a similar positive, significant association when 
comparing women whose BMI increased ≥ 3 units between consecutive pregnancies 
compared to those who maintained their weight. Bogaerts et al14 found a positive, 
significant association when comparing the same groups above at a higher magnitude 
(OR: 3.76 (95% CI: 2.16 – 6.57), but this was only seen in women whose first 
prepregnancy BMI was < 25 kg/m2. Hoff et al9 did not find any association between 
interpregnancy BMI change and the risk of gestational hypertension in the second 
pregnancy; however, they only included women who were overweight at their first 
prepregnancy measurement.  
4.4 NON-REPEAT CESAREAN DELIVERY 
We found no association between interpregnancy BMI change and risk of non-repeat C-
section. Several previous studies explored this same association but had mixed results. 
Villamor and Cnattigius3 found that those with a BMI increase of ≥ 3 units (compared to 
interpregnancy BMI maintenance) had odds of 1.32 (95% CI: 1.22 - 1.44) of a C-section 
in their second delivery. Villamor and Cnattingius3 did not exclude women with a C-
section in their first delivery from the denominator of their analysis. Although Getahun et 
al4 and Whiteman et al9 categorized their exposure differently than Villamor and 
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Cnattingius3 did, they found the same trend that as BMI increased so did odds of a non-
repeat C-section in the second delivery. Both Hoff et al6 and Bogaerts et al14 found that 
the association between increase in BMI and risk of C-section in the second pregnancy 
was only significant if women were categorized as overweight or obese in their first 
pregnancy. Although Paramsothy et al10 only included women with GDM in their first 
pregnancy, they also found that as BMI increases so does risk of C-section in the second 
delivery. Wallace et al15 did not find an association between an increase in BMI and the 
risk of neither elective nor emergency C-section in the second delivery; however, 
Wallace et al15 did not look at the outcome as a ‘non-repeat’ C-section as we did in the 
current study. 
4.5 VAGINAL BIRTH AFTER CESAREAN DELIVERY (VBAC) 
We found that a BMI increase of ≥ 3 units between consecutive pregnancies had a 
decreased rate of VBAC success (RR: 0.72 (95% CI: 0.58 – 0.88)). Only one of the 
previous studies explored this association and had similar results to ours11. Callegari et 
al11 found that those who increased their BMI ≥ 1 unit or < 2 units had an 8% decrease in 
VBAC success (95% CI: 2-13%). Similarly, they found that those who increased their 
BMI ≥ 2 units had a 12% decrease in VBAC success (95% CI: 7-17%)11. Their analysis 
only included women who were nulliparous at their first pregnancy11.  
4.6 FURTHER DISCUSSION 
The incidence rates of the outcomes measured in the current study were less than the 
national estimates18, 21. The discrepancy between these incident rates can be explained by 
the overall health status of the study population (Utah based) being better than the 
national population24. 
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Significant associations were found between interpregnancy BMI increase of 3 or 
more units and GDM, gestational hypertension, pre-eclampsia, and unsuccessful VBAC, 
when compared to those who maintained their interpregnancy BMI. To put this 
comparison into perspective, the Centers for Disease Control and Prevention reports that 
the average height of US women who are 20 years old and over is 162.1 cm20. For a 
woman of average height, a BMI unit change of 3 units is equivalent to gaining 
approximately 17.38 pounds between consecutive pregnancies. 
The biological mechanisms to explain the association between interpregnancy 
BMI gains and the adverse maternal outcomes of interest are speculative at best. Ros et al 
(1998)25 suggest that BMI impacts lipid metabolism, which in turn elevates the level of 
free fatty acids. As this level increases, insulin resistance increases via tumor necrosis 
factor alpha. This resulting insulin resistance is counteracted by hyperinsulinemia, which 
causes vasoconstriction. This vasoconstriction eventually leads to hypertension, which 
could be transient, i.e. gestational, or can become chronic. Ros et al (1998)25 also report 
that tumor necrosis factor alpha has been found to be at higher levels in pre-eclamptic 
women, which leads to endothelial dysfunction. The resulting insulin resistance 
mentioned above could also result in GDM, which is the manifestation of underlying beta 
cell dysfunction16. Again, these associations are hypothetical, but these adverse outcomes 
and obesity share several characteristics, such as inflammatory biomarkers, oxidative 
stress, and dyslipidemia26. Future research into the physiological biomarkers of these 
factors is needed26.  
The main strength of the current study was the combination of both EMRs and 
ICD-9 codes as data sources, which allowed us to gather extensive demographic, 
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diagnostic, and history information about study participants and many different 
outcomes. Further, as previously described, the majority of the previous studies that 
investigated the association between interpregnancy BMI change and adverse maternal 
outcomes utilized vital records data for analysis, which tend to underreport maternal 
complications27-30. Another strength of the current study was that the study population is 
homogeneous reducing the potential for residual confounding of the association of 
interest. The large sample size and retrospective US-based cohort design are further 
strengths of the current study. Unlike the Missouri cohort studies4-9 and Callegari et al11, 
we included women regardless of their parity. The results of the first sensitivity analysis, 
which only included nulliparous women, showed that there is no change in the magnitude 
and direction of the association between these two groups based on parity. Unlike several 
of the previous studies, the current study utilized Poisson regression with robust variance 
estimators allowing us to estimate relative risk, instead of odds ratios, as was done in 
previous studies3-6, 8-12, 14, 15.  
One limitation of the current study was the lack of information on diet, physical 
activity, and prenatal care of the study participants. Similarly, we lacked information 
about family history of hypertension and diabetes mellitus, as well as paternity, which 
may impact a woman’s risk of an adverse outcome in her second pregnancy. Change in 
paternity has been associated with elevated odds of pre-eclampsia23, but since the 
majority of the women in the current study were married, i.e. in stable relationships, at 
the time of the second pregnancy (90.42%), we do not expect this to impact our risk 
estimates. The prevalence of married women in the current study is higher than the 
national estimate of 41.5%24. The current study population was also predominantly white 
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(87.05%); thus, the generalizability of our findings is limited. The homogeneity of the 
population also limited our ability to analyze whether race was an effect modifier of the 
association of interest. Another limitation of the current study was that weight was self-
reported. However, because the exposure of interest was a difference in weight 
measurement between two consecutive pregnancies, this should not over or 
underestimate the exposure31-33.  
In conclusion, this retrospective, US-based cohort study filled a gap in the 
literature and provided evidence that there was a significant association between 
interpregnancy BMI gain and the risk of adverse maternal outcomes: gestational 
hypertension, pre-eclampsia, gestational diabetes mellitus, and unsuccessful VBAC, 
when comparing those with the highest BMI change (≥ +3 units) and those who 
maintained their BMI between pregnancies (-1 unit ≤ BMI < +1 unit). These findings are 
in line with previous studies and have public health implications for the importance of 
weight management between pregnancies.
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APPENDIX A: SUPPLEMENTARY TABLES 
Table A.1: Comparison of the demographics of those missing BMI data and those not 
missing BMI data 
 
Characteristic of the second pregnancy Missing BMI 
(n = 1546) 
Not missing BMI 
(n = 46521) 
p-value* 
Marital status, n (%)   <0.0001 
  Married 1303 (84.28) 42063 (90.42)  
  Divorced/Widowed 27 (1.75) 767 (1.65)  
  Single 215 (13.91) 3742 (7.93)  
Private insurance, n (%) 944 (61.06) 34498 (74.16) <0.0001 
Maternal race, n (%)   <0.0001 
  White 1038 (67.23) 40457 (87.05)  
  Hispanic 428 (27.72) 4691 (10.09)  
  Black/Asian/Pacific Islander/Other 1370 (5.05) 1328 (2.86)  
Lifestyle behaviors    
  Smoking during pregnancy 2, n (%) 65 (4.22) 1427 (3.07) <0.0001 
  Alcohol use during pregnancy 2, n 
(%) 
30 (1.95) 696 (1.50) 0.1568 
Gestational diabetes mellitus, n (%) 91 (5.89) 1646 (3.54) <0.0001 
Gestational hypertension, n (%) 37 (2.39) 1073 (2.31) 0.0673 
Pre-eclampsia, n (%) 21 (1.36) 791 (1.70) 0.8434 
Delivery mode, n (%)   0.0046 
  Vaginal birth 1195 (77.30) 36539 (78.54)  
  Vaginal birth after cesarean in first 
    delivery 
69 (4.46) 1685 (3.62)  
  Non-repeat cesarean in second 
    delivery 
53 (3.43) 1603 (3.45)  
  Repeat cesarean in second delivery 229 (14.81) 6693 (14.39)  
Maternal age, years, n (%)   <0.0001 
  < 35 1365 (88.29) 42268 (90.86)  
  ≥ 35 181 (11.71) 4253 (9.14)  
Maternal age, years, mean (SD) 27.90 (4.50) 27.97 (4.63)  
*Chi-square test  
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Table A.1 continued: Comparison of the demographics of those missing BMI data and 
those not missing BMI data 
 
Characteristic of the second pregnancy Missing BMI 
(n = 1546) 
Not missing BMI 
(n = 46521) 
p-value* 
Parity   0.0005 
  1 772 (49.94) 25429 (54.66)  
  2 359 (23.22) 10624 (22.84)  
  3 250 (16.17) 6461 (13.89)  
  4 102 (6.60) 2507 (5.39)  
  5 35 (2.26) 925 (1.99)  
  6+ 27 (1.81) 575 (1.24)  
Interpregnancy interval   <0.0001 
  0 – 5 months 137 (8.86) 2402 (5.16)  
  6 – 11 months 297 (19.21) 7536 (16.20)  
  12 – 17 months 359 (23.22) 11065 (23.78)  
  18 – 23 months 250 (16.17) 9630 (20.70)  
  24 – 59 months 489 (31.63) 15332 (32.96)  
  ≥ 60 months 14 (0.91) 556 (1.20)  
*Chi-square test 
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Table A.2: ICD-9 codes for maternal outcomes 
 
Outcome ICD-9 code Definition 
Pre-eclampsia 642.4 Mild or unspecified pre-eclampsia 
 642.5 Severe pre-eclampsia 
Gestational 
hypertension 
642.3 Transient hypertension of pregnancy 
Gestational diabetes 648.8 Abnormal glucose tolerance of mother 
complicating pregnancy, childbirth, or the 
puerperium 
Chronic hypertension 401 Essential hypertension 
   401.0   Malignant essential hypertension 
   401.1   Benign essential hypertension 
   401.9   Unspecified essential hypertension 
 402 Hypertensive heart disease 
   402.0   Malignant hypertensive heart disease 
   402.1   Benign hypertensive heart disease 
   402.9   Unspecified hypertensive heart disease 
 403 Hypertensive chronic kidney disease 
   403.0   Malignant hypertensive renal disease 
   403.1   Benign hypertensive renal disease 
   403.9   Unspecified renal disease 
 404 Hypertensive heart and chronic kidney 
disease 
   404.0   Malignant hypertensive heart and renal 
disease 
   404.1   Benign hypertensive heart and renal disease 
   404.9   Unspecified hypertensive heart and renal 
  disease 
 405 Secondary hypertension 
   405.0   Malignant secondary hypertension 
   405.1   Benign secondary hypertension 
   405.9   Unspecified secondary hypertension 
 642 Hypertension complicating pregnancy and 
childbirth and the puerperium 
   642.0   Benign essential hypertension 
   642.1   Hypertension secondary to renal disease 
   642.2   Other pre-existing hypertension 
 
